-

Allscripts Sunrise™ Wins Best in KLAS Award

Acute solution named 2020 Best in KLAS - Global Acute Care EMR (Canada)

RICHMOND, British Columbia--(BUSINESS WIRE)--KLAS Research named Allscripts (NASDAQ: MDRX) Sunrise™ as 2020 Best in KLAS - Global Acute Care EMR (Canada). Allscripts Sunrise Acute Care is a clinical solution that provides advanced decision support, such as Computerized Physician Order Entry (CPOE), to help hospital teams improve patient care. According to the 2020 Best in KLAS - Global Acute Care EMR (Canada) report, the solution outpaced competitors in delivering new technology and earning customer loyalty.

“Providers and payers demand better performance, usability, and interoperability from their vendor partners every year,” says Adam Gale, President of KLAS. “Best in KLAS winners set the standard of excellence in their market segment. Earning a Best in KLAS award should both excite and humble the recipients. It serves as a signal to providers that they can expect the best from the winning vendors.”

KLAS Research independently monitors healthcare technology performance through the active participation of users. Healthcare professionals evaluate the software they use, and KLAS Research analyzes and publishes the results in its annual Best in KLAS: Global Software (Non-US) report.

"This Best in KLAS award demonstrates Allscripts Sunrise comprehensive and flexible features that our clients require when facing today’s challenges in delivering complex care models,” said President of Allscripts Global, Alan Fowles. “Allscripts continues to focus on delivering industry leading, highly coordinated service to our clients globally and is proud that Sunrise is helping hospitals and health systems around the globe improve the clinician experience and provide quality patient care.”

Used by healthcare organizations across the globe, Allscripts Sunrise is an integrated electronic patient record that connects all aspects of care, including acute, ambulatory, surgical, radiology and personalized medicine. Built to enable efficient and safe care, Sunrise is a clinician-friendly, evidence-based single platform with advanced analytics that helps deliver true personalized medicine. Sunrise supports all core care venues across the enterprise by delivering a single patient record, and features patient-centric capabilities that can increase access and convenience for the consumer.

Allscripts celebrates this award with our Canadian clients who continue to deliver exceptional care every day.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

About KLAS

KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers to be heard and counted. Working with thousands of healthcare executives and clinicians, KLAS gathers data on software, services, medical equipment and infrastructure systems to deliver timely reports, trends and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving supplier performance. KLAS was founded in 1996, and their staff and advisory board average 25 years of healthcare information technology experience. Follow KLAS on Twitter at www.twitter.com/KLASresearch.

© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Contacts

For more information contact:
Investors:
Stephen Shulstein
312-386-6735
Stephen.Shulstein@allscripts.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com

Allscripts

NASDAQ:MDRX

Release Versions
Hashtags

Contacts

For more information contact:
Investors:
Stephen Shulstein
312-386-6735
Stephen.Shulstein@allscripts.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com

More News From Allscripts

Veradigm Announces Updated Presentation Time for Upcoming Investor Conference

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that it will now present at the 2026 Jefferies Healthcare Services and Technology Conference on September 15th at 3:35PM CT. A live webcast of the fireside chat will be available at the Veradigm investor relations website. About Veradigm® Veradigm has a proven history of delivering clinical and revenue cycle solutions that help independent pr...

Veradigm to Participate in Two Upcoming Investor Conferences

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management will be participating in the following investor conferences in September. 2026 Jefferies Healthcare Services and Technology Conference (Nashville, September 15, 2026) Don Trigg, Chief Executive Officer, and Christian Greyenbuhl, Chief Financial Officer, will hold one-on-one meetings and participate in a fireside chat on Tuesda...

Veradigm Files 2023 and 2024 Form 10-K

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today the filing of its comprehensive Annual Report on Form 10-K for the years ended December 31, 2023 and 2024 (the “2023 and 2024 Form 10-K”) with the Securities and Exchange Commission (“SEC”). “In our previous shareholder update, I framed a critical must-do to get current and stay current on our SEC filings. Today marks a major milestone in tha...
Back to Newsroom